ASLAN PHARMACEU/ADR (NASDAQ: ASLN) shares are trading at sub-$1 levels following a clinical readout from the company. Aslan, which went public in May 2018, said its varlitinib, codenamed ASLAN001, …
More Aslan Dips Into Penny Stock Territory After Company Flunks Late-Stage Cancer Study Videos